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Ovarian expressed microsomal epoxide hydrolase: Role in detoxification
of 4-vinylcyclohexene diepoxide and regulation by phosphatidylinositol-3
kinase signaling
Abstract
4-vinylcyclohexene diepoxide (VCD) is a metabolite of 4-vinylcyclohexene (VCH) which has the potential to
be formed in the ovary through CYP2E1 activity. VCD specifically destroys primordial and small primary
follicles in the rodent ovary. Mouse ovaries exposed to VCD demonstrate increased mRNA and protein
expression of microsomal epoxide hydrolase (mEH), and an inactive tetrol metabolite
(4-(1,2-dihydroxy)ethyl-1,2-dihydroxycyclohexane) can be formed in mouse ovarian follicles, potentially
through detoxification action of mEH. In contrast, mEH can bioactivate another ovotoxic chemical,
7,12-dimethylbenz[a]anthracene (DMBA) to a more toxic compound, DMBA-3,4-diol-1,2-epoxide. Thus,
the present study evaluated a functional role for mEH during detoxification of VCD. Additionally, because
inhibition of the phosphatidyinositol-3 kinase (PI3K) signaling pathway in a previous study protected
primordial follicles from VCD-induced destruction, but accelerated DMBA-induced ovotoxicity, a role for
PI3K in ovarian mEH regulation was evaluated. Using a post-natal day (PND) 4 Fischer 344 rat whole ovary
culture system inhibition of mEH using cyclohexene oxide during VCD exposure resulted in a greater (P <
0.05) loss of primordial and small primary follicles relative to VCDtreated ovaries. Also, relative to controls,
meh mRNA was increased (P < 0.05) on day 4 of VCD (30 μM) exposure, followed by increased (P < 0.05)
mEH protein after 6 days. Furthermore, inhibition of PI3K signaling increased mEH mRNA and protein
expression. Thus, these results support a functional role for mEH in the rat ovary, and demonstrate the
involvement of PI3K signaling in regulation of ovarian xenobiotic metabolism by mEH.
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Abstract
4-vinylcyclohexene diepoxide (VCD) is a metabolite of 4-vinylcyclohexene (VCH) which has the
potential to be formed in the ovary through CYP2E1 activity. VCD specifically destroys
primordial and small primary follicles in the rodent ovary. Mouse ovaries exposed to VCD
demonstrate increased mRNA and protein expression of microsomal epoxide hydrolase (mEH),
and an inactive tetrol metabolite (4-(1,2-dihydroxy)ethyl-1,2-dihydroxycyclohexane) can be
formed in mouse ovarian follicles, potentially through detoxification action of mEH. In contrast,
mEH can bioactivate another ovotoxic chemical, 7,12-dimethylbenz[a]anthracene (DMBA) to a
more toxic compound, DMBA-3,4-diol-1,2-epoxide. Thus, the present study evaluated a
functional role for mEH during detoxification of VCD. Additionally, because inhibition of the
phosphatidyinositol-3 kinase (PI3K) signaling pathway in a previous study protected primordial
follicles from VCD-induced destruction, but accelerated DMBA-induced ovotoxicity, a role for
PI3K in ovarian mEH regulation was evaluated. Using a post-natal day (PND) 4 Fischer 344 rat
whole ovary culture system inhibition of mEH using cyclohexene oxide during VCD exposure
resulted in a greater (P < 0.05) loss of primordial and small primary follicles relative to VCD-
treated ovaries. Also, relative to controls, meh mRNA was increased (P < 0.05) on day 4 of VCD
(30 μM) exposure, followed by increased (P < 0.05) mEH protein after 6 days. Furthermore,
inhibition of PI3K signaling increased mEH mRNA and protein expression. Thus, these results
support a functional role for mEH in the rat ovary, and demonstrate the involvement of PI3K
signaling in regulation of ovarian xenobiotic metabolism by mEH.
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The ovary is the primary reproductive organ in females, and contains follicles at various
stages of development. The primordial follicle is the most immature form, and consists of a
meiotically-arrested oocyte surrounded by a single layer of squamous granulosa cells.
Females are born with a finite number of primordial follicles, which once depleted, cannot
be replaced (Hirshfield, 1991). The phosphatidylinositol-3 kinase (PI3K) signaling pathway
is critically involved in maintaining primordial follicle viability (Parrott and Skinner, 1999;
Yoshida et al., 1997) and regulates the rate at which primordial follicles are recruited into
the growing follicular pool (Yoshida et al., 1997; Kissel et al., 2000; Castrillon et al., 2003;
Reddy et al., 2005; John et al., 2008; Reddy et al., 2008). This survival pathway is activated
when granulosa cell-expressed Kit Ligand (KITL) binds to the oocyte expressed receptor, c-
KIT (Ismail et al., 1996). In response, c-KIT undergoes autophosphorylation, which leads to
activation of PI3K (Castrillon et al., 2003; Reddy et al., 2005; John et al., 2008; Liu et al.,
2006; Reddy et al., 2008), eventually resulting in phosphorylation of a key downstream
molecule, AKT (Nicholson and Anderson, 2002; Datta et al., 1999).
Exposure to a chemical that accelerates depletion of the finite primordial follicle pool can
lead to premature ovarian failure. 4-vinylcyclohexene (VCH) is a byproduct of the pesticide,
rubber, plastic and flame retardant industries (Rappaport and Fraser, 1977). Bioactivation of
VCH to the ovotoxic form, 4-vinylcyclohexene diepoxide (VCD) occurs via the cytochrome
P450 family of enzymes, including ovarian expressed CYP 2E1 (Cannady et al., 2002;
2003; Rajapaksa et al., 2007a). Human exposure to VCH and VCD are limited, however,
VCD is a useful model ovotoxicant due to its capacity to selectively destroy primordial and
small primary follicles in ovaries of mice and rats (Smith et al., 1990; Doerr et al., 1985).
The enzyme microsomal epoxide hydrolase (mEH) is expressed in multiple tissues,
including the ovary, and has wide substrate specificity (Dannan and Guengerich, 1982;
Mukhtar et al., 1978). mEH mRNA and enzyme activity expression were shown to increase
in small pre-antral follicles of mouse ovaries following repeated daily dosing (15d) with
VCD (0.57 mmol/kg/day) (Cannady et al., 2002). Furthermore, mEH mRNA and protein
were up-regulated in cultured postnatal day 4 (PND4) B6C3F1 mouse ovaries in response to
VCD exposure (Keating et al., 2008a), and formation of the inactive tetrol metabolite [4-
(1,2-dihydroxy)ethyl-1,2-dihydroxycyclohexane] in ovarian follicles of VCD dosed mice
has been demonstrated (Flaws et al., 1994). Based on these collective data, a functional role
for mEH in VCD detoxification is hypothesized but has not yet been established.
In contrast to VCD, the ovotoxic polycyclic aromatic hydrocarbon, 7,12-
dimethylbenz[a]anthracene (DMBA), liberated during combustion of organic matter
(Gelboin, 1980), destroys follicles at all stages of development (Mattison and Schulman,
1980). A study in which an ovotoxic index (concentration required for 50% primordial
follicle loss) was calculated found that DMBA is approximately 20 times more ovotoxic
than VCD (Borman et al., 2000). It has been demonstrated that DMBA is bioactivated to a
more potent ovotoxicant DMBA-3,4-diol, 1,2-epoxide via the mEH enzyme (Rajapaksa et
al., 2007; Igawa et al., 2009). Thus, mEH is involved in bioactivation of DMBA and the
action of mEH enhances the ovotoxic effects of DMBA.
Inhibition of PI3K protects primordial but not small primary follicles from VCD-induced
destruction (Keating et al., 2009). In contrast, ovarian DMBA exposure during inhibition of
PI3K accelerates the amount of ovotoxicity observed (Keating et al., 2009). Due to the
divergent role of mEH in bioactivation of DMBA and potential detoxification of VCD, it is
proposed that changes in mEH action may be involved in the different levels of ovotoxicity
observed with these two chemicals during PI3K inhibition (Figure 1). The purpose of this
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study therefore was to 1) establish that mEH has a functional role in VCD detoxification
and, 2) to investigate if the previously observed divergent levels of ovotoxicity induced by




4-vinylcyclohexene diepoxide (VCD), bovine serum albumin (BSA), ascorbic acid,
transferrin, cyclohexene oxide (CHO), 2-β-mercaptoethanol, 30% acrylamide/0.8%
bisacrylamide, ammonium persulphate, glycerol, N’N’N’N’-Tetramethylethylenediamine
(TEMED), Tris base, Tris HCL, sodium chloride, Tween-20 were purchased from Sigma-
Aldrich Inc. (St Louis, MO). Dulbecco’s Modified Eagle Medium: nutrient mixture F-12
(Ham) 1x (DMEM/Ham’s F12), Albumax, penicillin (5000U/ml), Hanks’ Balanced Salt
Solution (without CaCl2, MgCl2 or MgSO4) from Invitrogen Co. (Carlsbad, CA). Millicell-
CM filter inserts and 48 well cell culture plates were obtained from Millipore (Bedford,
MA) and Corning Inc. (Corning, NY) respectively. RNeasy Mini kit, QIA shredder kit,
RNeasy Min Elute kit, and Quantitect™ SYBR Green PCR kit were purchased from Qiagen
Inc (Valencia, CA). RNAlater was obtained from Ambion Inc. (Austin, TX). With the
exception of 18S rRNA primers, all primers were obtained from IDT (Coralville, IA). The
18S rRNA primer was obtained from Applied Biosystems (Carlsbad, CA). 2-(4-
morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002; CAS#154447-36-6) was
purchased from A.G. Scientific, Inc. (San Diego, CA). The mEH antibody was purchased
from Detroit R and D (Detroit, MI). Donkey anti-goat secondary antibody was purchased
from Vector (Burlingame, CA). The polyclonal β-actin and goat anti-rabbit secondary were
obtained from Santa Cruz Biotechnology, (Santa Cruz, CA) and Pierce Biotechnology
(Rockford, IL) respectively. Ponceau S was from Fisher Scientific. ECL plus chemical
luminescence detection kit was obtained from GE Healthcare, Amersham
(Buckinghamshire, UK).
Animals
All animals were housed one per cage in plastic cages and maintained in a controlled
environment (22 ± 2°C; 12h light/12h dark cycles). The animals were provided a standard
diet with ad libidum access to food and water, and allowed to give birth. All animal
experimental procedures were approved by the University of Arizona and Iowa State
University Institutional Animal Care and Use Committees.
In vitro ovarian cultures
Ovaries were collected from PND4 female F344 rats and cultured as described by Devine et
al., 2002. Briefly, PND4 female F344 rat pups were euthanized by CO2 inhalation followed
by decapitation. Ovaries were removed, trimmed out of oviduct and other excess tissues and
placed onto Millicell-CM membrane floating on 250 μl of DMEM/Ham’s F12 medium
containing 1 mg/ml BSA, 1 mg/ml Albumax, 50 μg/ml ascorbic acid, 5 U/ml penicillin and
27.5 μg/ml transferrin per well in a 48 well plate previously equilibrated to 37°C. A drop of
medium was placed on top of each ovary to prevent it from drying. Ovaries were treated
with vehicle control medium (1% DMSO), VCD (30 μM), the PI3K inhibitor LY294002 (20
μM), and/or the mEH inhibitor CHO (2 mM) and maintained at 37°C and 5% CO2 for 2-8
days. The concentrations of LY294002 and CHO were previously determined to be effective
in the PND4 rat ovary culture system (Keating et al., 2009; Igawa et al., 2009, respectively).
For treatments lasting for more than two days, media was changed every alternate day. The
concentration (30 μM) and times of VCD exposure (day 6) were previously determined to
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cause 50% primordial and small primary follicle loss (Devine et al., 2002; Keating et al.,
2009).
Histological evaluation of follicle numbers
Following treatment, ovaries were placed in Bouin’s fixative for 1.5 hr, paraffin embedded
and serially sectioned (5 μM). Every 6th section was mounted and stained with hematoxylin
and eosin. Healthy oocyte-containing follicles were identified and counted in every 12th
section. Unhealthy follicles were distinguished by their granulosa cell content of pyknotic
bodies and intense eosinophilic staining of oocytes (Devine et al., 2002). Follicle population
classification was performed as previously described (Keating et al., 2009).
RNA isolation and polymerase chain reaction (PCR)
Following 2, 4, 6 or 8 days of in vitro culture, ovaries were stored in RNA later at −80°C.
Total RNA was isolated from ovaries (n=3; 10 ovaries per pool) using an RNeasy Mini kit
according to the manufacturer’s instructions. RNA was eluted in 14 μl of RNase-free water
and concentration quantified using a NanoDrop (λ=260/280 nm; ND 1000; Nanodrop
Technologies Inc, Wilmington, DE). Total RNA (500 ng) was reverse transcribed to cDNA
using Superscript III One- Step RT-PCR System (Invitrogen). Genes of interest were
amplified using an Eppendorf mastercycler (Hauppauge, NY) using a Quantitect™ SYBR
Green PCR kit (Qiagen Inc.Valencia, CA). The primers used were: meh forward primer:
5′GGC ATC GTC CAT AAA CA; meh reverse primer: 5′ TCT TCA AAG GCA GCA AAG
TG, (NCBI GenBank accession number M26125), β-actin forward primer: 5′ TCT ATC
CTG GCC TCA CTG TC; β-actin reverse primer: 5′ACG CAG CTC AGT AAC AGT CC,
(NCBI GenBank accession number NM_007393) and commercially available primers to
detect 18S rRNA. A melting curve analysis was used to ensure that a single product was
amplified for each primer set. For the VCD experiments, there was no effect of VCD on β-
actin mRNA expression, thus, meh mRNA was normalized to β-actin. Inhibition of PI3K did
result in decreased β-actin mRNA expression, thus, 18S rRNA was used as a housekeeping
gene for the PI3K inhibition experiments, since there was no impact of PI3K inhibition on
18S rRNA expression. Quantification of fold-change in gene expression was performed
using the 2−ΔΔCt method (Pfaffl, 2001; Livak and Schmittgen, 2001). The PCR conditions
used were: 15 min hold at 95°C and 40 cycles of: denaturing at 95°C for 15 s, annealing at
58°C for 15 s, and extension at 72°C for 15 s.
Protein isolation and Western blot analysis
Following 4, 6 or 8 days of culture, protein was isolated from ovaries (n=3; 10 ovaries/pool)
as previously described (Thompson et al., 2005). Protein concentration was measured using
a standard BCA protocol. Emission absorbance values were detected with a λ=540 nm
excitation on a Synergy™ HT Multi-Detection Microplate Reader using KC4™ software
(BioTekR Instruments Inc. Winooski, VT).
SDS-PAGE (10%) was used to separate proteins (10 μg; n=3) in the homogenates followed
by transfer onto nitrocellulose membranes as previously described (Thompson et al., 2005).
Membranes were blocked for 1 h with shaking at 4°C in 5% milk in Tris-buffered saline
with Tween-20 (TTBS). Membranes were incubated with primary antibody in 5% milk in
TTBS overnight at 4°C. The mEH antibody dilution used was 1:2000. Following three
washes (10 min) in TTBS, membranes were incubated in HRP-conjugated secondary
antibody (1:2000) for 1hr at room temperature. Membranes were washed three times (10
min) in TTBS followed by a single wash for 10 min in Tris Buffered Saline (TBS).
Membranes were incubated in chemiluminescence detection substrate (ECL plus) for 5 min
and exposed to X-ray film. Densitometry of the appropriate bands was performed using
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ImageJ software (NCBI). Equal protein loading was confirmed by Ponceau S staining of
membranes and mEH protein was normalized to Ponceau S densitometry values.
Statistical analysis
Comparisons were made between treatments for follicle count experiments using Statview
software analysis of variance (ANOVA). Quantitative RT-PCR and Western blotting data
were analyzed by paired t-tests comparing treatment with control raw data at each individual
time-point using Prism 5.04 software (GraphPad Software). Statistical significance was
defined as P < 0.05. For graphical purposes, protein expression is presented as a percentage
of the respective controls, and only one control value of 100% is presented.
Results
Effect of mEH inhibition on VCD-induced ovotoxicity in PND4 rat ovaries
Cyclohexene oxide (CHO) is a competitive inhibitor of mEH. In order to evaluate a
functional role for mEH in VCD-induced ovotoxicity, F344 rat ovaries were cultured in
vehicle control or VCD (30 μM) ± CHO (2 mM) for 8 days, followed by histological
evaluation of follicles. This time-point was chosen since primordial and small follicle
destruction is established at this time (Keating et al., 2009). There was no effect of CHO on
primordial follicle number. Relative to control, VCD depleted (P < 0.05) primordial follicles
by 74.5%. When ovaries were exposed to VCD in the presence of mEH inhibition (CHO),
there was greater (P < 0.05) primordial follicle loss (36% fewer follicles) relative to VCD
alone (Figure 2). Surprisingly, there was an effect of CHO on small primary follicle number
(32.5% fewer follicles than control treatment; P < 0.05). As expected, relative to control,
VCD depleted (P < 0.05) small primary follicles (57.5% fewer follicles). Inhibition of mEH
in the presence of VCD resulted in additional loss (P < 0.05) of small primary follicles
compared to VCD alone (55% fewer small primary follicles; Figure 2).
Effect of VCD exposure on meh mRNA in PND4 rat ovaries
It has previously been determined that VCD exposure (30 μM) causes significant loss of
both primordial and small primary follicles from 6 days of exposure onwards in cultured
PND4 F344 rat ovaries (Keating et al., 2009). To determine the temporal pattern of meh
mRNA expression in response to VCD exposure, PND4 F344 ovaries were cultured in VCD
(30 μM) for 2-8 days (Figure 3). Relative to control treated ovaries, there was no change in
meh mRNA level following 2 days of VCD exposure. On day 4 of VCD exposure, there was
an increase (P < 0.05) in meh mRNA expression (0.61-fold increase) and a trend for
increased meh mRNA after 6 days (0.51-fold, P = 0.08; Figure 3).
Effect of VCD exposure on mEH protein in PND4 rat ovaries
Since mEH mRNA level did not change until 4 days after VCD exposure, changes in mEH
protein levels were investigated on days 4, 6 and 8 (Figure 4). There was no effect of VCD
on mEH protein level at the 4 day time-point, but mEH protein was increased (P < 0.05)
after 6 and 8 days of VCD exposure, by 26 and 17%, respectively, relative to control.
Effect of PI3K inhibition on ovarian expression of mRNA encoding meh
To investigate a potential role of PI3K signaling in regulation of meh, PND4 F344 ovaries
were cultured in vehicle control ± LY294002 (20 μM; PI3K inhibitor) for 2 or 4 days
followed by quantitative RT-PCR to determine changes in mRNA encoding meh. The
housekeeping gene 18S rRNA was used as an internal control because PI3K inhibition
affected the mRNA level for β-actin (data not shown). There was a decrease (P < 0.05) in
meh mRNA expression following 2 days of PI3K inhibition (0.51-fold decrease) compared
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to vehicle control. In contrast, meh mRNA expression was increased (P < 0.05) by PI3K
inhibition after 4 days (1.21-fold increase; Figure 5).
Effect of PI3K inhibition on ovarian expression of mEH protein
To evaluate the effect of PI3K inhibition on mEH protein, PND4 F344 rat ovaries were
cultured in vehicle control ± LY294002 for 4 and 6 days (time-points lagging the mRNA
increase) followed by Western blotting to detect mEH protein levels. Due to the observed
effects of PI3K on the mRNA encoding the cytoskeleton protein, β-actin, Ponceau S staining
was used to confirm equal protein loading across samples and densitometry values for mEH
were normalized to those of Ponceau S. mEH protein was significantly increased (P < 0.05)
by PI3K inhibition by 221% on day 4 and 14% on day 6 relative to control-treated ovaries
(Figure 6).
Discussion
Previously, it has been shown that VCD exposure to cultured PND4 B6C3F1 mice resulted
in increased mEH mRNA and protein levels (Keating et al., 2008a). It has also been
demonstrated that follicles isolated from ovaries of VCD-dosed mice produce an inactive
tetrol metabolite, [4-(1,2-dihydroxy)ethyl-1,2-dihydroxycyclohexane] (Flaws et al., 1994),
potentially through the action of mEH. Demonstration of a functional role for mEH during
VCD detoxification, however, has been lacking, therefore this study investigated a
functional effect of mEH during VCD exposure, using the competitive inhibitor of mEH,
cyclohexene oxide (CHO), followed by assessment of follicle number. CHO has previously
been determined to be effective in the ovary culture system at the concentration used (Igawa
et al., 2009). As expected, VCD depleted primordial and small primary follicle number.
While there was no impact on primordial follicle number, surprisingly, small primary
follicle number was reduced by mEH inhibition (in the absence of VCD). mEH protein is
distributed throughout the rat ovary, including the cytoplasm of oocytes, and in granulosa
and interstitial cells (Igawa et al., 2009). In humans, mEH protein has been detected in
granulosa and theca interna cells, where inhibition of mEH in cultured granulosa cells was
found to result in decreased Estradiol (E2) production from testosterone (Hattori et al.,
2000), independent of an effect on aromatase activity. Female aromatase knockout mice
(ArKO) are deficient in E2 and have higher numbers of primary follicles relative to age
matched control mice indicating increased activation from the primordial follicle pool (Britt
et al., 2002). Thus, E2 may inhibit primordial follicle activation supporting that the
decreased number of small primary follicles due to mEH inhibition in the current study may
reflect some increased recruitment from the small primary pool as a consequence of
decreased estradiol production. When mEH was inhibited in the presence of VCD, relative
to VCD alone, there was greater loss of both primordial follicles and small primary follicles,
and loss of small primary follicles was greater than that caused by CHO alone. Since
inhibition of mEH would result in exposure to greater persistent concentrations of VCD,
these data provide confirmation that ovarian mEH is involved in detoxification of VCD.
meh mRNA was increased in cultured rat ovaries in response to VCD, following 4 days of
exposure. Additionally, an increase in mEH protein was observed to follow the increase in
mRNA (d4 mRNA; d6 protein). Interestingly, the rise in meh mRNA expression was not
sustained, despite continuous exposure to VCD. However, mEH protein levels remained
elevated, indicating either an increase in mEH protein expression or an extension of mEH
protein half-life. Thus, these data confirm that mEH expression is activated in PND4
cultured rat ovaries in a temporal response to VCD exposure. It is likely that despite the
increase in ovarian mEH level, that continuous exposure (every two days) to VCD
overwhelms the capacity of mEH to detoxify VCD, leading to loss of primordial and small
primary follicles,
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In a previous study, inhibition of PI3K signaling resulted in decreased ovotoxicity induced
by VCD, but accelerated DMBA-induced ovotoxicity (Keating et al., 2009). These results
suggested that an alteration in metabolism of VCD and DMBA might be occurring. Further,
a role for mEH in mediating the divergent ovotoxic effects of VCD and DMBA in CYP 2E1
null mice has been reported (Keating et al., 2008b). Thus, mEH is an ovarian expressed
enzyme whose action may determine the extent of ovotoxicity caused by exposure to
different xenobiotic chemicals.
To further investigate regulation of mEH expression in ovarian tissue, a specific inhibitor of
PI3K signaling, LY294002, was employed. After two days in culture, meh mRNA was
decreased, potentially due to a lag in transcriptional activation. Conversely, PI3K inhibition
resulted in increased meh mRNA on days 4. mEH protein was increased by PI3K inhibition
on days 4 and 6. These results indicate that mEH is downstream of PI3K signaling. Whether
PI3K signaling is altered during mEH inhibition by CHO is unclear at this point, but is
possible considering the effect of mEH deficiency on small primary follicle number.
Increased mEH mRNA and protein supports that increased VCD detoxification and DMBA
bioactivation are likely to be involved in the previously observed reduction in VCD-induced
follicle loss and the increase in DMBA-induced follicle loss observed with PI3K inhibition
(Keating et al., 2009).
The PI3K pathway has been identified as a major initial target of VCD (Keating et al.,
2011). VCD exposure to cultured PND4 rat ovaries reduces c-KIT phosphorylation (Mark-
Kappeler et al., 2011), resulting in downstream post-translational reductions in oocyte
phosphorylated AKT (pAKT) and FOXO3 proteins (Keating et al., 2011). Depressed PI3K
signaling by VCD exposure is consistent with the increase in mEH protein caused by both
VCD and PI3K inhibition reported in the current study. Insulin has been reported to
positively regulate hepatic mEH expression (Thomas et al., 1989 Kim et al., 2003; Kim and
Novak, 2007) while glucagon inhibits mEH expression (Kim et al., 2003). Induction of Type
I diabetes, characterized by insulin deficiency, in rats resulted in approximately 71% less
mEH activity compared to the littermate controls. Treatment with insulin restored the
activity of mEH. In addition, starvation, a physiological state known to reduce insulin levels,
reduced mEH activity by approximately 33% of the control values in rats, while re-feeding
restored mEH to control levels (Thomas et al., 1989). Thus, insulin plays a role in induction
of mEH activity. It has also been shown that treatment of cultured primary rat hepatocytes
with insulin increased mEH mRNA and protein in a time- and concentration-dependent
manner (Kim et al., 2003), while use of the PI3K inhibitors, Wortmannin and LY294002,
reduced pAKT level and prevented the insulin-induced increase in mEH (Kim et al., 2003),
supporting that PI3K signaling is involved in insulin-induced hepatic regulation of mEH.
Use of mTOR inhibitor, rapamycin, also prevented the insulin-induced induction of mEH
protein (Kim et al., 2003). Recently, mTOR phosphorylated at position Ser2448 (activated
form) was demonstrated to be increased by DMBA exposure in neonatal mouse ovaries
(Sobinoff et al., 2011). Another study has demonstrated the involvement of PI3K signaling
in induction of mEH through the transcription factors C/EBPα and C/EBPβ (Ki and Kim,
2008). Taken together, these data support a role for PI3K signaling in regulation of ovarian
metabolism by mEH, potentially through the action of mTOR or C/EBP transcription
factors, and also support that mEH is a downstream target of PI3K. Whether over-
stimulation of PI3K signaling would further alter ovarian metabolism of VCD and DMBA is
unclear at this point, however there are indications that altered insulin signaling (through
PI3K) as seen during diabetes, can impact mEH expression in extra-ovarian tissues (Thomas
et al., 1989; Kim and Novak, 2007).
In summary, a functional role for ovarian expressed mEH in VCD detoxification has been
demonstrated, along with the temporal response of mEH mRNA and protein to VCD
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exposure. Results from the current study also support that PI3K signaling impacts mEH
expression. These results further underline the potential impact of ovarian xenobiotic
metabolism on the extent of follicular damage during chemical-induced ovotoxicity.
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Highlights of this research
• Ovarian mEH functions to metabolize VCD to a less toxic compound
• mEH expression is increased in a temporal pattern in response to VCD exposure
• PI3K signaling is involved in regulation of ovarian mEH expression
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Figure 1. Proposed effect of PI3K inhibition on VCD- and DMBA-induced ovotoxicity
PI3K signaling is proposed to regulate mEH expression. (A) VCD and DMBA both cause
depletion of primordial follicles, however, (B) inhibition of PI3K signaling repressed VCD-
induced but accelerated DMBA-induced ovotoxicity (Keating et al., 2009). These events are
proposed to be due to increased mEH expression (B) since mEH is proposed to detoxify
VCD, and is known to bioactivate DMBA (Igawa et al., 2009). Thus, the divergent levels of
ovotoxicity observed due to inhibited PI3K signaling during VCD and DMBA exposure are
hypothesized to be due to increased detoxification of VCD, but increased bioactivation of
DMBA.
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Figure 2. Effect of mEH inhibition on VCD-induced follicle loss
PND4 F344 rat ovaries were cultured in media containing vehicle control or VCD (30 μM),
± CHO (2 mM) for 8 days. Ovaries were processed for histological evaluation and healthy
follicles were classified and counted as described in methods. Values are expressed as mean
± SE total follicles counted/ ovary, n=5. Different letters indicate significant difference; P <
0.05.
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Figure 3. Temporal effect of VCD on meh mRNA expression
PND4 F344 rat ovaries were cultured in media containing vehicle control (CT) or VCD (30
μM) for 2-8 days. Following incubation, total RNA was isolated and meh and β-actin
mRNA levels were quantified by RT-PCR as described in methods. Values are expressed as
mean fold change ± SE; n=3 (10 ovaries per pool). * P < 0.05; different from control.
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Figure 4. Temporal effect of VCD on mEH protein expression
PND4 F344 rat ovaries were cultured in media containing vehicle control (CT) or VCD (30
μM) for 4-8 days. Total protein was isolated and Western blotting was performed for mEH
protein as described in methods. (A) Representative Western blot day 6; Control = C; VCD
= V. (B) Values are expressed as a percentage of control mean ± SE; n=3 (10 ovaries per
pool). * P < 0.05; different from control.
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Figure 5. Effect of PI3K inhibition on meh mRNA expression
PND4 F344 rat ovaries were cultured in media containing vehicle control (CT), ± 20 μM
LY294002 for 2 or 4 days. Total RNA was isolated and meh and 18S rRNA levels were
quantified by RT-PCR as described in methods. Values are expressed as mean fold change ±
SE; n=3 (10 ovaries per pool). * P < 0.05; different from control.
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Figure 6. Temporal effect of PI3K inhibition on mEH protein
PND4 F344 rat ovaries were cultured in media containing vehicle control (CT), ± 20 μM
LY294002 for 4 or 6 days. Total protein was isolated and Western blotting was performed to
detect mEH protein. (A) Representative Western blot is shown on day 4; Control = C;
LY294002 = L. (B) Values are expressed as a percentage of control mean ± SE; n=3 (10
ovaries per pool). * P < 0.05; different from control.
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